Background. The authors reviewed their long-term experience with pediatric renal transplantation into a dysfunctional lower urinary tract to evaluate the results of contemporary lower urinary tract evaluation and management on graft survival and function.
Renal transplantation in pediatric patients is highly successful (1) . However, transplantation into the dysfunctional lower urinary tract (DLUT) has been associated with relatively high complication rates (2, 3) and inferior graft survival according to historic case series (4 -6) . With the evolution of lower urinary tract evaluation (7, 8) and management using anticholinergic medications, clean intermittent catheterization (CIC) (9 -11) , and bladder augmentation procedures (12, 13) in the past 20 years, improvements in renal function and lower urinary tract preservation have been accomplished in the majority of pediatric patients with congenital lower urinary tract anomalies.
Contemporary studies have indicated that renal transplantation outcomes in adult patients with DLUT are comparable to those observed in patients with normal lower urinary tracts (NLUT) (14 -16) . However, there are limited data regarding the results of transplantation in the pediatric population (17) . A distinction between pediatric and adult patients needs to be emphasized, because adherence to strict timed voiding schedules and CIC regimens is far more challenging in the pediatric and adolescent population, placing these patients at greater risk for upper tract deterioration. We hypothesize that with rigorous lower tract follow-up and compliance with contemporary techniques in the management of lower tract dysfunction, pediatric renal transplant patients can maintain excellent long-term graft survival and function in accordance with the excellent results seen in the adult population. In this report, we compared the long-term outcomes of pediatric renal transplantation in children with DLUT with outcomes in children with NLUT during the 1990s at the University of Pittsburgh Medical Center.
PATIENTS AND METHODS

Patient Demographics
Between 1990 and 1996, 21 renal allografts were transplanted into 20 patients with DLUT (18 male patients and 2 female patients). Over the same period of time, 61 renal allografts were transplanted into 61 patients with NLUT (26 male patients and 25 female patients). Patients were followed for a minimum of 36 months (mean, 62.0Ϯ19.6 months; range, 36 -98 months) from the time of transplantation. Patient demographics are shown in Table 1 . Patients were comparable in all demographic categories except for the cold ischemia time, which was higher in the DLUT group than in the NLUT group (Pϭ0.008).
DLUT Patients
The cause of lower urinary tract dysfunction included 13 patients with posterior urethral valves (PUV), four with prune belly syndrome (PBS), two with meningomyelocele, and one with urethral atresia-imperforate anus syndrome. Preoperatively, patients with lower urinary tract dysfunction were evaluated using voiding cys-tourethrography (VCUG), renal ultrasonography, and urodynamics (cystometrography, postvoid residual urinary volume).
Preoperative Lower Urinary Tract Evaluation and Management
Using these urodynamic studies, patients were managed according to their degree of bladder dysfunction. We categorized patients into separate groups according to lower tract management (Table 2) . In group 1, six patients with low postvoid residuals and low terminal bladder pressures were considered to have safe bladder storage parameters and were managed with timed voiding. These patients were otherwise allowed to void spontaneously. In group 2, eight patients had adequate bladder capacities, but because of poor bladder wall compliance parameters or elevated postvoid residual volumes, clean intermittent catheterization with or without anticholinergic medications were necessary to reduce terminal bladder pressures and postvoid residuals. In group 3a, the two patients with preexisting bladder augmentations (enterocystoplasty) displayed excellent storage capacity and bladder compliance. The two patients in group 3b had small, fibrotic, noncompliant bladders and therefore required bladder augmentation (ureterocystoplasty) at the time of transplantation. All patients in groups 3a and 3b were required to perform CIC to reduce postvoid residual volumes postoperatively. Patients in group 4 had preexisting urinary diversions. The first child, who was diagnosed with urethral atresia-imperforate anus syndrome and a dysplastic right kidney, had a left cutaneous pyelostomy created shortly after birth. The second child had a right cutaneous pyelostomy after having undergone bilateral nephrectomy for complications from PBS. They were not candidates for undiversion, because of inability or reluctance to perform CIC. Therefore, they received transplants into their supravesical diversions.
Postoperative Lower Urinary Tract Evaluation and Management
Postoperative upper tract sonography was performed in all patients. Urodynamic assessment was performed in selected patients who were at risk for upper tract deterioration from lower tract dysfunction (Table 3 ). In addition, all patients were placed on prophylactic antibiotics three times weekly.
Immunosuppression
All patients received tacrolimus-prednisone immunosuppression, without antibody induction. Target tacrolimus and corticosteroid dosing was performed according to guidelines previously published by our group (1). In addition, corticosteroids were completely withdrawn 6 months posttransplantation in 85% of DLUT (17 of 20) and 90% of NLUT (55 of 61) patients. These patients have remained steroid-free at last follow-up. Rejection episodes were treated with a bolus and recycle of corticosteroids as previously described by our group (1). Corticosteroid-resistant rejections were treated with antilymphocyte antibody therapy. a Lower tract management of patients was determined according to pretransplant urodynamic evaluation. Patients were classified into groups according to lower urinary tract management. The urodynamic characteristics of patients in these groups are represented in this table.
CIC, Clean intermittent catheterization. Patient and graft survival rates were calculated using KaplanMeier cumulative survival plots and groups were compared using the log-rank (Mantel-Cox) chi-square test. Other data were assessed using the Student t test and analysis of variance. Data are expressed as meanϮSD. A value of PϽ0.05 was used to indicate statistical significance. Figure 1 shows the patient and graft survival data. The mean follow-up duration in this study was 62.0Ϯ19.6 months (range, 36 -92 months). The 5-year actuarial patient survival rates were 100% and 95% in the DLUT and NLUT groups, respectively (Pϭnot significant [NS]). Overall, there were three deaths, all in the NLUT group and all related to sepsis. The 1-and 5-year actuarial graft survival rates were 100% and 83% in DLUT patients, and 97% and 69% in NLUT patients, respectively (PϭNS). The two graft losses in the DLUT group were attributed to biopsy-proven chronic rejection and were not related to lower tract dysfunction. In both cases of graft loss in this group, the causes of DLUT were PUV and PBS, and these patients had been managed with timed voiding alone. Table 4 lists the cause for graft loss in both DLUT and NLUT groups.
RESULTS
Patient and Allograft Survival
Allograft Function
The mean serum creatinine in the DLUT and NLUT patients with functioning grafts was 1.3Ϯ0.5 and 1.3Ϯ0.7 mg/dL at 3 years, respectively (PϭNS). Renal function in the DLUT patients was similar regardless of DLUT management: mean serum creatinine was 1.2Ϯ0.4 mg/dL in patients who were managed by timed voiding, 1.5Ϯ0.7 mg/dL in patients who required CIC, 1.3Ϯ0.3 mg/dL in patients with bladder augmentation, and 1.2Ϯ0.3 mg/dL in patients who underwent transplantation into their urinary diversions (all PϭNS).
Biopsy-proven rejection occurred in 62% (13 of 21) of DLUT patients and in 48% (30 of 61) of patients with NLUT (PϭNS). All rejection episodes in DLUT patients were reversed with a steroid recycle, whereas 4 of 30 (13%) NLUT patients with rejection required OKT3 therapy for steroidresistant rejection.
Lower Tract Function
Patients with DLUT were managed according to preoperative bladder function as determined by urodynamic evaluation. Postoperative reevaluation with urodynamics was performed if complications arose or if bladder augmentation was performed at the time of transplantation. Terminal bladder pressures greater than 40 cm H 2 O were considered detrimental to upper tract function, and pressures less than 20 cm H 2 O were considered to be consistent with safe storage (7, 18) . The consequence of bladder pressures between 20 and 40 cm H 2 O was less clear. In general, these patients were managed with CIC if there were any other abnormalities in urodynamic parameters.
Six patients were managed with timed voiding alone (group 1). These patients had an adequate mean bladder capacity (187Ϯ254 mL), low mean terminal pressure of 18Ϯ8 cm H 2 O, and low mean postvoid residual urinary volumes (19Ϯ15 mL). Although two grafts were lost to chronic rejection in this group, the remaining patients continued to void spontaneously without the need for anticholinergic medications or CIC. Postoperatively, one patient developed a urinary tract infection. Subsequently, he was reevaluated with urodynamics and VCUG. All urodynamic parameters remained within acceptable limits ( Table 3) .
The eight patients managed with CIC with or without anticholinergic medication demonstrated adequate preoperative bladder capacities (mean, 198Ϯ92 mL). However, ter- Chronic rejection (2) Chronic rejection (2) Death with functioning graft (2) Recurrent disease (5) minal bladder pressures were moderately elevated (26Ϯ5 cm H 2 O), necessitating CIC and a timed voiding regimen. Two patients were reevaluated with urodynamics after postoperative urologic complications (urinary infection and stricture). Again, postoperative functional bladder characteristics did not change appreciably (Table 3) .
Two of four children in the bladder augmentation group underwent enterocystoplasty before renal transplantation. Preoperative bladder function was excellent in these patients (terminal bladder pressure, 6Ϯ1 cm H 2 O; bladder capacity, 450Ϯ141 mL). Postoperatively, patients continued with CIC to optimize bladder drainage. One child developed a spontaneous bladder perforation 5 months posttransplantation, despite good preoperative function. The perforation sealed spontaneously, and after urodynamic reevaluation of the lower urinary tract, it was found that her bladder capacity had decreased from 600 mL to 350 mL, with a concomitant increase in terminal bladder pressure from 5 cm H 2 O to 31 cm H 2 O. Therefore, the frequency of CIC was increased from four to six times daily and anticholinergic medications were added to increase terminal bladder volumes to greater than 300 mL.
Two children had ureterocystoplasties performed at the time of transplantation, because of unacceptably high terminal bladder pressures (82Ϯ10 cm H 2 O) and low bladder capacities (46.6Ϯ6 mL), respectively. Urodynamics performed postoperatively confirmed that these augmented bladders were capable of safe urinary storage (Table 3) .
Poor bladder capacity (47Ϯ33 mL) and unacceptably high terminal bladder pressures (66Ϯ20 cm H 2 O) rendered the final group of two patients candidates for bladder augmentation. However, refusal to self-catheterize in one and the inability to self-catheterize in another patient (cerebellar ataxia from Klippel-Feil syndrome) precluded the option of bladder augmentation in these two cases. Therefore, they received transplants into their preexisting supravesical urinary diversions.
Urologic Complications
Seven of 20 patients (35%) experienced 10 urologic complications. Four surgical procedures were required to manage these complications (Table 5 ). In the six patients managed with timed voiding alone (group 1), one developed an uncomplicated bacterial urinary tract infection, which responded to antibiotics. Two of eight patients managed with CIC alone (group 2) developed urologic complications. One patient had an uncomplicated urinary infection; the other patient (with a history of PUV) developed a filamentous urethral stricture that responded to simple urethral dilatation. Three of four transplants into augmented bladders (group 3) were followed by urologic complications. The first patient, who had a preexisting enterocystoplasty, developed a spontaneous bladder perforation several months posttransplantation. The perforation sealed spontaneously and the patient was treated by prolonged urethral catheterization alone. In addition, she later formed bladder stones, which were treated by cystolithopaxy. She subsequently developed two uncomplicated bacterial urinary tract infections over the next 2 years. VCUG did not demonstrate vesicoureteral reflux. Urodynamic assessment documented high terminal bladder pressures, and she was managed with increased CIC frequency and anticholinergic medication. During the subsequent 2 years, no further complications occurred. The two other patients in this group developed pyelonephritis associated with severe vesicoureteral reflux. These patients had nontunneled ureteral implantations at the time of the transplantation. Both patients were managed with successful tunneled ureteroneocystostomies, eliminating reflux and recurrent upper tract infection. One month posttransplantation, one patient also developed a urethral stricture, which was eventually managed by cutaneous vesicostomy, because CIC through the diseased urethra proved too arduous a task for this patient's family. No complications occurred in the two patients who received transplants into their preexisting urinary diversions (group 4). (Tables 2 and 3 ). Only two patients were unable or unwilling to perform CIC, and the allografts were therefore transplanted into their urinary diversions. Despite varying degrees of lower tract dysfunction, long-term graft outcome was virtually identical among this group of patients. As a group, overall patient and graft survival and function were equivalent when NLUT and DLUT patients were compared. This suggests that good long-term renal function may be maintained if stable lower urinary tract pressures can be achieved using CIC, timed voiding, medical therapy, and augmentation cystoplasty. Although supravesical diversion has been historically associated with inferior graft survival and high complication rates (3, 4) , excellent long-term renal function and low complication rates were achieved in the two patients with low-pressure urinary diversions as well. Because the results of renal transplantation into the DLUT had been historically poor (2), our excellent results are a testament to the diligent preoperative workup and postoperative surveillance required to maintain upper tract integrity. Five patients (25%) developed urologic complications requiring surgical intervention, and two others (10%) had uncomplicated urinary tract infections, consistent with the high complication rates found in other studies (3, 14, 15) . The two cases of urethral strictures were likely related to complications from the original disease (PUV). One patient developed a spontaneous bladder perforation, recurrent urinary infections, and bladder stone formation, all of which are welldocumented complications of enterocystoplasty (19, 20) . Despite acceptable pretransplant urodynamic parameters, these patients need to be followed closely, with emphasis on strict adherence to timed voiding and CIC schedules to minimize the frequency of these complications. In the same patient, urodynamic surveillance demonstrated that bladder functional characteristics had deteriorated, necessitating an increase in CIC frequency. We therefore recommend that VCUG, upper tract imaging, and urodynamic reassessment of the lower urinary tract be performed after the occurrence of any urologic complication. The two patients who had bladder augmentations performed at the time of transplantation developed pyelonephritis associated with high-grade vesicoureteral reflux. Both patients required tunneled reimplantation of the transplant ureters at a later date. Because of these complications, we now recommend that every attempt be made to perform tunneled ureteral reimplantation at the time of transplantation in patients with DLUT. This holds especially true in patients with bladder augmentations. Because these patients are at an increased risk for lower tract colonization with bacteria (19), a nonrefluxing ureteroneocystostomy would prevent the ascension of bacteria into the upper urinary tract. Although our urologic complication rate was high, no grafts were lost as a result of lower tract dysfunction. This highlights the importance of diligent lower urinary tract evaluation, surveillance, and management in this complex group of patients, both before and after transplantation.
